vanillic acid has been researched along with Leishmaniasis, Visceral in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S; Sane, SA; Shakya, N | 2 |
| Bajpai, P; Gupta, S; Sane, SA; Shakya, N; Vishwakarma, P | 1 |
| Gupta, S; Ramesh, SC; Srivastava, VM | 1 |
| Goyal, N; Gupta, N; Mittal, N; Rastogi, AK; Roy, U; Saksena, S | 1 |
| Dhawan, BN; Guru, PY; Kulshreshtha, DK; Puri, A; Saxena, KC; Saxena, RP | 1 |
6 other study(ies) available for vanillic acid and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Proliferation; Cinnamates; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycosides; Leishmania donovani; Leishmaniasis, Visceral; Lymphocytes; Male; Mesocricetus; Paromomycin; Phagocytosis; Phosphorylcholine; Random Allocation; Reactive Nitrogen Species; Reactive Oxygen Species; Vanillic Acid | 2011 |
Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv.
Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Drug Therapy, Combination; Fluconazole; Glycosides; Hydrogen Peroxide; Immunity, Cellular; Leishmania donovani; Leishmaniasis, Visceral; Phagocytosis; Phosphorylcholine; Reactive Oxygen Species; Treatment Outcome; Vanillic Acid | 2011 |
Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv.
Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Glycosides; Hydrogen Peroxide; Immunologic Factors; Ketoconazole; Leishmania donovani; Leishmaniasis, Visceral; Male; Phagocytosis; Phosphorylcholine; Reactive Nitrogen Species; Reactive Oxygen Species; Rodent Diseases; Treatment Outcome; Vanillic Acid | 2011 |
Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; Antiprotozoal Agents; Biopsy; Cinnamates; Cricetinae; Drug Interactions; Drug Therapy, Combination; Female; Glycosides; Leishmania donovani; Leishmaniasis, Visceral; Male; Mesocricetus; Parasitemia; Phosphorylcholine; Picrorhiza; Vanillic Acid | 2005 |
Protective effect of Picroliv from Picrorhiza kurroa against Leishmania donovani infections in Mesocricetus auratus.
Topics: Administration, Oral; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Bilirubin; Cinnamates; Cricetinae; Drug Therapy, Combination; Glucose-6-Phosphatase; Glutamate Synthase; Glycosides; Leishmania donovani; Leishmaniasis, Visceral; Lipid Peroxidation; Liver; Mesocricetus; Plant Extracts; Succinate Dehydrogenase; Vanillic Acid | 1998 |
Immunostimulant activity of Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters.
Topics: Adjuvants, Immunologic; Animals; Antigens, Protozoan; Cinnamates; Cricetinae; Female; Glycosides; Leishmania donovani; Leishmaniasis, Visceral; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Plants, Medicinal; Vanillic Acid | 1992 |